CD274 and neoplasm: Expression of Programmed cell death ligand 1 (PD-L1) on the tumor cell surface did not prove to be a reliable predictive biomarker for either response or survival, as checkpoint inhibitors are also efficient in PD-L1 negative tumors [12,13,14].